Drug or technology

Difluprednate Ophthalmic

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Difluprednate Ophthalmic (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to difluprednate ophthalmic; does not report clinical trial outcomes or comparative efficacy data.

Regulatory UpdateSandoz Difluprednate Ophthalmic